secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K/A
Filed at:   2025-01-27T23:59:59+00:00
Accession:  0001493152-25-003676
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric corrects reverse stock split effective date to January 29, 2025
-----------------------------------------------------------------------

- Reverse stock split of 1-for-15 will begin trading on Nasdaq Capital Market on January 29, 2025 (previously January 27).
- Post-split CUSIP number: 29405E 406; trading symbol remains ENVB.
- Amendment filed solely to correct the effective date; original split approved by board and stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315225003676/0001493152-25-003676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315225003676/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer